ABSTRACT Microtubule-associated proteins (MAPs) promote tubulin polymerization, whereas coichicine inhibits this process. In this paper, MAPs have been shown to inhibit colchicine binding to tubulin in a competitive manner. Attempts were made to identify which of the MAPs fraction(s) was responsible: both tau protein (a thermostable molecule with a molecular weight of --70,00) and a high molecular weight fraction (HMW) were able to compete with colchicine. In contrast, MgZ+, which also induces microtubule assembly in vitro, had no effect on colchicine binding to tubulin.
Microtubules are organelles found in all eukaryotic cells and are implicated in several cellular processes. They are formed by polymerization of 6S tubulin subunits. The assembly process is inhibited by colchicine both in vivo and in vitro when this drug binds to a specific site on tubulin (1-3). We report herein that endogenous brain factors inhibit the binding of colchicine to tubulin, competitively. To identify these factors we assumed that they should have, like colchicine, a high affinity for tubulin. Thus, if such factors exist, one might predict that they would copurify with tubulin in the microtubule assembly process in vitro. Microtubules assembled in vitro contain several minor protein components that have been referred to as microtubule-associated proteins (MAPs). Several of these proteins are believed to play a role in the microtubule assembly process (4) (5) (6) (7) (8) . We have therefore investigated whether MAPs inhibit colchicine binding to tubulin.
EXPERIMENTAL PROCEDURE Rat brain microtubules were purified by two cycles of polymerization, using the assembly-disassembly procedure described by Shelanski et al. (9) . Pure (10) . The MAPs fraction thus obtained was either dialyzed against 100mM Mes buffer (100 mM Mes/0.5 mM MgCl2/1.0 mM EGTA/0.1 mM EDTA/1.0 mM 2-mercaptoethanol/1 mM GTP, pH 6.4) or filtered on Sephadex G-25 equilibrated with the same buffer to remove the NaCl. Two fractions present in the MAPs were purified by column chromatography. These fractions were the tau protein described by Weingarten et al. (4) and high molecular weight (HMW) components isolated by Murphy and Borisy (5) . Tau and HMW proteins were purified by chromatography on an LKB Ultrogel AcA 34 polyacrylamide/agarose column. The total MAPs fraction eluted from the phosphocellulose column was applied (5 mg protein in 1 ml) to an AcA 34 column (40 X 1.5 cm) equilibrated with the same buffer. Fractions were collected and dialyzed against 100 mM Mes buffer, pH 6.4, to remove NaCl and then tested for their activity (in promoting the assembly of pure tubulin).,.Their protein contents were determined by the Lowry method (11). The purity of tubulin and MAPs fractions was established by sodium dodecyl sulfate gel electrophoresis as described by Weber et al. (12) . The molecular weight of tau protein was estimated in polyacrylamide gel electrophoresis with the tubulin subunit (molecular weight 55,000) as a reference marker.
Tubulin assembly in vitro at 370C was followed by turbidimetric measurements at 345 nm with a Zeiss PM 6 KS spectrophotometer with an automatic thermostated four-sample changer.
Colchicine binding to tubulin was assayed in 100 mM Mes buffer with, or without, 4 M glycerol. Pure tubulin (concentrations ranging from 0.2 mg/ml to 0.25 mg/ml depending on the experiment) was incubated at 37'C for 2 hr in a final volume of 0.5 ml in the presence of different colchicine concentrations, labeled with 0.1 jACi (1 Ci = 3.7 X 10'0 becquerels) of [3H]colchicine per assay. Bound colchicine was measured according to a modification (13) One explanation for these results might be the following: The assembly of pure tubulin is markedly enhanced by MAPs (4, 8, 10) ; self-assembly is achieved in the absence of MAPs, but only at protein concentrations higher than 2.5 mg/ml (14) . In the presence of MAPs, the minimal concentration [critical concentration, Cc, (15, 16) ] that is required is ;10 times lower.
Because colchicine binds only to free tubulin (1-3) or rings (17) and not to microtubules (1-3), the inhibition by MAPs of colchicine binding (Figs. 1 and 2 (Fig. 1 ) and in the presence (Fig. 2) of glycerol show that MAPs did not modify the Cmax, the number of sites available to colchicine. A decrease in the number of sites would be expected if the MAPs reduced the number of free tubulin molecules-i.e., molecules having an unmasked colchicine binding site. In Fig. 1 It is possible that the decrease in the colchicine binding affinity described in Figs. 1 and 2 could be due to the formation of rings, which would have a lower affinity for colchicine than free tubulin.
Because MAPs are made up of several entities (4-8), an attempt was made to identify the factor(s) responsible for this inhibition more precisely. It has been reported that two protein fractions from MAPs promote in vitro tubulin polymerization: tau factor, described by Weingarten et al. (4) , and HMW proteins (MAPs1 and MAPs2) described by several authors (5-8).
These two groups of proteins therefore could be candidates as inhibitors of colchicine binding to tubulin.
The tau protein and HMW fractions were isolated from the MAPS as previously described (10) and their purities and compositions were determined by sodium dodecyl sulfate gel electrophoresis (10) . Purified tau factor migrated as a broad peak composed of several closely spaced bands with molecular weights ranging from 57,000 to 63,000; i.e., the factor was very similar to the thermostable factor described by Witman et al. (19) . HMW proteins were mainly composed of several high molecular weight species; this is in agreement with data obtained by other authors (8) .
As seen in Fig. 3 , the tau factor inhibits colchicine binding to tubulin very efficiently; tau factor did not modify the Cmax, but markedly decreased the KA. The inset of figure 3 shows that this fraction is very active in inducing 6S tubulin polymerization.
The second main component of MAPs, HMW proteins, likewise inhibits colchicine binding to tubulin (Fig. 4) and also has a moderate effect on tubulin assembly (Fig. 4, inset) .
These findings are consistent with the idea that both tau and HMW proteins inhibit colchicine binding either to the free tubulin or to the rings and other protofilaments that might be formed below the critical concentration for tubulin assembly (19, 20) . In either case, however, the colchicine binding site is not completely masked by the two MAPs, tau and HMW. Our data show that it is not the number of colchicine binding sites that is reduced in the presence of MAPs, but rather a modification in the affinity of tubulin for this drug, which accounts for these results. Frigon In conclusion, the data reported above are consistent with the idea that endogenous factors competitively inhibit colchicine binding by the free tubulin molecule or by the rings that may be formed below the critical concentration required for microtubule assembly. Either the factors and colchicine bind to the same site or the factors modify the affinity of the colchicine binding site in the process of ring formation. The most reasonable mechanism is a simple reversible binding of MAPs to tubulin in a region that overlaps with (or fully contains) the colchicine binding site.
